The Czech Association of Pharmaceutical Companies represents manufacturers and suppliers of off-patent medicines in the Czech Republic, including those producing and supplying critical medicines. We welcome the Commissions proposal and its overarching objectives.
Česká asociace farmaceutických firem
Industry association · Czechia
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Česká in PolicySpeak: request access →
Work at Česká asociace farmaceutických firem? so we know who speaks for it.
Their record over time
Česká asociace farmaceutických firem filed 2 positions between 27 Feb 2025 and 6 Jul 2025, across 1 of the 673 legislative files tracked here.
What they argued
CAFF welcomes the Commissions initiative to halt the relocation of pharmaceutical manufacturing outside the EU, strengthen supply chains, and enhance self-sufficiency to prevent medicine shortages. However, achieving these goals requires coordinated action across multiple EU and national authorities. Fragmented competences and insufficient collaboration pose a major risk to success. Key Considerations 1.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Česká asociace farmaceutických firem next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Česká asociace farmaceutických firem’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.